Detalles de la búsqueda
1.
PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses.
Eur J Immunol
; 54(3): e2350770, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38088451
2.
Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry.
Eur J Immunol
; 54(1): e2350616, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37840200
3.
Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways.
J Biol Chem
; 299(11): 105276, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37739035
4.
Guidelines for mouse and human DC generation.
Eur J Immunol
; 53(11): e2249816, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303448
5.
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
Int J Mol Sci
; 24(2)2023 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674907
6.
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
Eur J Immunol
; 51(6): 1494-1504, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33675038
7.
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.
Proc Natl Acad Sci U S A
; 116(17): 8463-8470, 2019 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962374
8.
Three distinct tolerogenic CD14+ myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.
J Autoimmun
; 120: 102645, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33901801
9.
Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
Cancer Immunol Immunother
; 67(9): 1425-1436, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019146
10.
EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells.
Front Immunol
; 15: 1355769, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38343540
11.
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential.
Cell Rep Med
; 5(2): 101386, 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38242119
12.
Human Dendritic Cell Subset Isolation by Magnetic Bead Sorting: A Protocol to Efficiently Obtain Pure Populations.
Bio Protoc
; 13(20): e4851, 2023 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37900109
13.
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
J Immunother Cancer
; 10(4)2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35428705
14.
Recent Advances and Future Perspective of DC-Based Therapy in NSCLC.
Front Immunol
; 12: 704776, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34262573
15.
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.
Oncoimmunology
; 10(1): 1935557, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34239773
16.
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
Front Immunol
; 11: 631713, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33679726
17.
Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination.
Cell Rep
; 30(4): 1027-1038.e4, 2020 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31995747
18.
STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics.
J Immunol Res
; 2019: 7458238, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31309123
19.
Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
Front Immunol
; 9: 1169, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29904379
20.
Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.
Front Oncol
; 8: 127, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29755954